Probity Advisors
GMED icon

Probity Advisors’s Globus Medical GMED Stock Holding History

Probity Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$266K Buy
3,553
+78
+2% +$6.18K 0.04% 208
2026
Q2 		$275K Sell
3,475
-38
-1% -$3.23K 0.04% 207
2026
Q1 		$303K Sell
3,513
-15
-0.4% -$1.35K 0.05% 203
2025
Q4 		$308K Sell
3,528
-264
-7% -$20K 0.05% 197
2025
Q3 		$217K Buy
3,792
+199
+6% +$11.5K 0.04% 227
2025
Q2 		$212K Buy
+3,593
New +$232K 0.04% 226

Other funds holding GMED

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.43B AUM 15.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Anchor Capital Advisors
Anchor Capital Advisors Boston, Massachusetts $3.21B AUM 13.78% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Probity Advisors's GMED Position: Q3 2026 in Review

Probity Advisors increased its Globus Medical (GMED) stake by 2.2% in Q3 2026, buying an estimated $6.18K and bringing the position to 3,553 shares worth $266K. The position accounts for 0.04% of the portfolio, ranked #208.

Probity Advisors first reported a position in GMED in Q2 2025 and has held it in 6 quarters since. The position peaked at $308K in Q4 2025. 295 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • Probity Advisors held 3,553 shares of Globus Medical worth $266K as of Q3 2026.
  • Probity Advisors bought 78 Globus Medical shares in Q3 2026, an estimated $6.18K.
  • Globus Medical made up 0.04% of Probity Advisors's portfolio in Q3 2026, its #208 holding.
  • Probity Advisors first reported a position in Globus Medical in Q2 2025 and has held it in 6 quarters since.
  • Probity Advisors's Globus Medical position peaked at $308K in Q4 2025.
  • 295 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Probity Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.